Abstract

BackgroundNo strategy has yet proved successful in monitoring tuberculosis (TB) infection during treatment with TNF antagonists. Even the new interferon-gamma (IFN-γ) release assays (IGRAs) produce dynamic changes in IFN-γ plasma...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call